FDA NDC Directory · JSON-LD · Markdown

Levothyroxine sodium

NDC 0480-8682 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207588
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (25 ug/1)
Marketing started20220921
Marketing ended20260831
Package count2

External sources

Source: openFDA. Public-domain (CC0).